CLINICAL TRIALS OFFER HOPE ON THE HORIZON
Our Goal: A Healthier Nevada for All
“ Through this new publication, Clinical Connections, we look to create a healthier future for all by connecting clinicians, healthcare professionals, researchers and patients with a robust network of support, innovation and best practices in healthcare. In doing so, we hope the physicians at Renown Health become your preferred partners for exceptional patient care, and your colleagues in learning and discovery.”
At Renown Health, we recognize the vital role that healthcare providers play in delivering essential care to their communities. We understand the unique challenges you face in managing complex cases, often with limited resources and without immediate support. Inside this issue, you will read how our worldclass team of surgical experts is bringing essential services, hope and lifesaving treatment to people in the communities we serve. Now, patients in need of advanced procedures no longer need to endure long waits or seek care in other states, which will help alleviate the financial, physical and emotional burden for critically ill patients and their families.
Renown Health’ s physicians and leadership team are deeply committed to building stronger clinical connections with you to ensure that no matter where a patient receives care, they have access to the same high standards of treatment. Together, we can enhance the quality of care provided to patients across rural and urban communities and strengthen the entire clinical network.
Thank you for the important work you do each day.
CLINICAL TRIALS OFFER HOPE ON THE HORIZON
As the first academic and clinical research enterprise in Nevada, Renown Health and the University of Nevada, Reno School of Medicine partner to provide access to the region’ s most advanced clinical trials. Our Office of Clinical Research supports numerous research efforts in various specialties and actively seeks new collaborations. Dozens of open clinical trials, including these, are currently underway at Renown Health.
GENETICS STUDY TITLE: M / NASH Full protocol title: Nonalcoholic Steatohepatitis Liver Disease Genome Atlas Indication: Metabolic and nonalcoholic steatohepatitis Phase: II PI name: Joseph Grzymski, PhD Phone number: 775-982-6914
ONCOLOGY STUDY TITLE: EXAI CP-23001 Full protocol title: A Prospective Study of oncRNA Stratification of Cancer by Size and Stage Indication: multi-disease site cancer stratification by size and stage & healthy controls NCT number: NCT05833360 Phase: Not Applicable PI name: Lee Schwartzberg, MD Phone number: 775-982-5050
PEDIATRICS STUDY TITLE: VAD00004( PEARL) Full protocol title: Efficacy, Immunogenicity, and Safety Study of a Respiratory Syncytial Virus Vaccine in Infants and Toddlers Indication: Respiratory syncytial virus( RSV) NCT number: NCT06252285 Phase: II PI name: Sonia Budhecha, MD Phone number: 775-982-3646
PULMONOLOGY STUDY TITLE: PROACT-LUNG Full protocol title: The PROACT LUNG Study: A Prospective, Observational, Clinical Validation Study of the Freenome Multiomics Blood Test for Lung Cancer Screening( FRNM-007) Indication: Lung cancer NCT number: 06122077 Phase: Observational PI name: Farah Madhani- Lovely, MD Phone number: 775-982-7532
RHEUMATOLOGY STUDY TITLE: TOPAZ-2 230LE304 Full protocol title: A Multicenter, Randomized, Double-Blind, Placebo- Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Litifilimab( BIIB059) in Adult Participants With Active Systemic Lupus Erythematosus Receiving Background Nonbiologic Lupus Standard of Care Indication: Systemic lupus erythematosus( SLE) NCT number: 04961567 Phase: IIII PI name: Kennedy Ukadike, MD Phone number: 775-982-6128
Brian Erling, MD, MBA President & CEO, Renown Health Brian. Erling @ renown. org
USE THIS QR CODE TO LEARN MORE ABOUT OPEN CLINICAL TRIALS AVAILABLE AT RENOWN HEALTH.
VOLUME 1, ISSUE 1 | Renown Health | 3